Medical Director, Clinical Development-Rheumatology

• MD or equivalent medical degree is required.

• Clinical expertise in rheumatology is required, with board certification in rheumatology preferred.

• Typically 3 or more years of relevant clinical development or clinical research experience is preferred, with pharmaceutical or biotechnology industry experience strongly preferred; academic clinical research experience may also be considered.

• Experience leading or materially contributing to interventional clinical trials, including protocol development, medical monitoring, data review, and study reporting, is required.

• Experience with deep depletion approaches or chimeric antigen receptor (CAR) T-cell therapy is desirable.

• Lead the design, execution, analysis, and reporting of Phase 2 and Phase 3 rheumatology trials, aligned with clinical development strategy and regulatory requirements.

• Serve as medical lead for assigned studies, including eligibility guidance, medical monitoring, safety review, protocol deviation assessment, and benefit-risk evaluation.

• Lead cross-functional study teams and drive timely decisions, risk mitigation, and delivery of study milestones.

• Develop and review clinical documents, including study concepts, protocols, investigator brochures, statistical analysis inputs, clinical study reports, and publications.

• Contribute medical content to regulatory submissions, briefing packages, health authority responses, and regulatory interactions.

• Interpret emerging clinical, translational, and competitive evidence and translate it into actionable development recommendations.

• Build effective relationships with investigators, external experts, patient organizations, and development partners.

• Support evaluation of new mechanisms, modalities, and external opportunities relevant to rheumatology and autoimmune disease.

• Mentor clinical team members and contribute to a collaborative, inclusive, and high-accountability culture.